Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Cytometry A ; 75(9): 743-51, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19582873

RESUMEN

Analysis of the T-cell receptor (TCR) repertoire by flow cytometry proved to be relevant for investigating T-cell diversity and detecting reactive cells in blood samples. We used this approach to characterize non-malignant T-lymphocytes in lymph nodes and give insights into their origin. The TCR repertoire of CD4+ and CD8+ T-cells from 81 lymph nodes was analyzed with a four-color flow cytometer using a wide panel of 25 anti-Vbeta monoclonal antibodies. Flow cytometry proved to be a useful and informative technique. We demonstrated a diversified TCR-Vbeta repertoire, and only low level expansions, in 53% of the samples. They involved nearly all Vbeta families, were more frequent in the CD8+ subset of older patients, but were not related to pathology. No evidence could be demonstrated in favor of stimulation by common antigens. Interestingly, the TCR-Vbeta repertoire proved to be very similar in lymph nodes and blood samples. Our results argue that in the cases studied, lymph node enlargement is mainly due to an increased homing of circulating T-cells. They also provide reference values for expression of 25 TCR-Vbeta in lymph nodes, which could serve as a basis for further applications in diagnosis of T-cell lymphoproliferative disorders.


Asunto(s)
Citometría de Flujo/métodos , Inmunofenotipificación/métodos , Ganglios Linfáticos/patología , Receptores de Antígenos de Linfocitos T alfa-beta/sangre , Adenocarcinoma/inmunología , Adenocarcinoma/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/patología , Niño , Femenino , Enfermedad de Hodgkin/inmunología , Enfermedad de Hodgkin/patología , Humanos , Ganglios Linfáticos/inmunología , Linfoma de Células B/inmunología , Linfoma de Células B/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Seudolinfoma/inmunología , Seudolinfoma/patología , Valores de Referencia , Adulto Joven
2.
Clin Exp Dermatol ; 33(6): 712-4, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18681887

RESUMEN

Interstitial granulomatous dermatitis (IGD) is a recently described, rare dermatological entity. The clinical features are diverse and the precise aetiology is unknown. We present a rare and atypical case of IGD in a patient with systemic lupus erythematosus (SLE). A 26-year-old woman had been diagnosed with SLE when she was 15 years old. The diagnosis was based on cutaneous, articular, pulmonary, haematological and immunological features. The patient presented with a cutaneous diffuse macular eruption on the limbs, appearing in a cockade (rosette) pattern with a violaceous centre and erythematous surround. The face and trunk were spared. The cutaneous histological features led us to consider a diagnosis of IGD. The lesions disappeared after 15 days of systemic steroid therapy. This case is a new clinical form of IGD with an atypical location and clinical presentation. IGD has usually been associated with drug-related adverse reactions and autoimmune diseases. Reports in the literature of IGD in patients with SLE are rare.


Asunto(s)
Dermatitis/complicaciones , Lupus Eritematoso Sistémico/complicaciones , Piel/patología , Adulto , Azatioprina/uso terapéutico , Dermatitis/diagnóstico , Dermatitis/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Glucocorticoides/uso terapéutico , Humanos , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Prednisolona/uso terapéutico , Warfarina/uso terapéutico
3.
Ann Dermatol Venereol ; 135(10): 657-62, 2008 Oct.
Artículo en Francés | MEDLINE | ID: mdl-18929914

RESUMEN

BACKGROUND: Lymphomatoid papulosis (LyP) is a rare lymphoproliferative disorder. It is now included in the World Health Organisation (WHO) classification of cutaneous lymphomas. Although frequently described in adults, there have been only a few reported cases of LyP in children; diagnosis is often difficult in this population and no clear guidelines have been established regarding management or monitoring. In this article we report six new cases of LyP in children. PATIENTS AND METHODS: This is a retrospective study of six children, aged between two and 11 years, seen at the Hôtel-Dieu Hospital in Lyon and at the Grenoble Hospital Centre between 2005 and 2008. Each child underwent skin biopsy for histological and immunohistochemical analysis. RESULTS: All six children presented papulonodular lesions on the limbs and trunk, in some cases necrotic, present for different times and developing in episodes. Histology and immunolabelling announces in all six cases militated in favour of LyP type A, with large CD30+ and CD15- cells dispersed in an inflammatory dermal infiltrate made up for the most part of lymphocytes, polynuclear neutrophils, eosinophils and a small number of histiocytes. DISCUSSION: Only around 60 cases of LyP have so far been reported in children, principally type A. Association with malignant lymphoma occurs, with high risk in relation to the general population of the same age. Clinical diagnosis is confirmed histopathology and immunolabelling. There is currently no consensus regarding therapeutic management. First-line treatment generally comprises therapeutic abstention or dermal corticosteroids. Methotrexate and phototherapy constitute possible alternatives but should be used only in very disseminate or debilitating forms of the disease. CONCLUSION: The presentation and course of LyP of childhood differs very little from the adult form. Cases of associated lymphoma have been reported. Although regular clinical monitoring is recommended, there is no call for routine laboratory testing.


Asunto(s)
Papulosis Linfomatoide/patología , Neoplasias Cutáneas/patología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Estudios Retrospectivos
4.
Ann Dermatol Venereol ; 135(12): 848-51, 2008 Dec.
Artículo en Francés | MEDLINE | ID: mdl-19084696

RESUMEN

BACKGROUND: Secondary skin sites of lymphoma appear in the advanced stages of the disease. We report the first case of a pericicatricial skin infiltration, mimicking febrile dermohypodermitis, revealing diffuse immunoblastic large B-cell non-Hodgkin's lymphoma. PATIENTS AND METHODS: Four months after decompressive cervical laminectomy, a 56-year-old man presented an inflammatory pericicatricial patch evoking cellulitis in a setting of hyperthermia and lymphadenopathy. Blood cultures and bacteriological analysis of skin biopsy samples were negative. The images showed infiltration of the soft subcutaneous areas and polyadenopathy. Two weeks later, several subcutaneous nodules appeared on the trunk. Histological analysis and immunolabelling pointed to immunoblastic large B-cell non-Hodgkin's lymphoma. A clone of B lymphocytes CD45+, CD20+, CD79a+, Bcl2+, CD5+, MUM1+, CD3-, CD10-, CD23- and Bcl6- was seen. The remainder of the extension examination was negative. CHOP-rituximab polychemotherapy resulted in complete regression of all lesions, notably the inflammatory cervical plaque. DISCUSSION: Secondary skin manifestations of lymphoma are generally non-specific (pruritus, ichthyosis, purpura, etc.) rather than specific in terms of lymphoid infiltration. As in our patient, certain cutaneous sites of lymphoma may have a misleading clinical presentation, histological analysis alone was able to provide a conclusive diagnosis. In our patient, the highly specific infiltration seen around the entire scar could either suggest a Koebner phenomenon or point to a role of the cutaneous aggression within the development of an inflammatory process contributing to pericicatricial infiltration by lymphoid cells. Locoregional invasion from the osseous part of the cervical spine and not macroscopically diagnosed during neurosurgery could also be responsible.


Asunto(s)
Celulitis (Flemón)/diagnóstico , Neoplasias de Cabeza y Cuello , Linfoma de Células B , Linfoma Inmunoblástico de Células Grandes , Neoplasias Cutáneas , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Antineoplásicos/administración & dosificación , Antineoplásicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , Celulitis (Flemón)/patología , Cicatriz/patología , Ciclofosfamida/uso terapéutico , Diagnóstico Diferencial , Doxorrubicina/uso terapéutico , Neoplasias de Cabeza y Cuello/diagnóstico , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/patología , Humanos , Inmunohistoquímica , Linfoma de Células B/diagnóstico , Linfoma de Células B/tratamiento farmacológico , Linfoma de Células B/patología , Linfoma Inmunoblástico de Células Grandes/diagnóstico , Linfoma Inmunoblástico de Células Grandes/tratamiento farmacológico , Linfoma Inmunoblástico de Células Grandes/patología , Masculino , Persona de Mediana Edad , Prednisona/uso terapéutico , Rituximab , Piel/patología , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Resultado del Tratamiento , Vincristina/uso terapéutico
5.
Rev Pneumol Clin ; 62(2): 80-6, 2006 Apr.
Artículo en Francés | MEDLINE | ID: mdl-16670660

RESUMEN

Primary tumors are relatively rare in the pleura. Histological types include mesothelioma, epitheliod, biphasic or sarcomatoid tumors as well as primary lymphoma and mesenchymatous tumors which include solitary fibrous tumor, epithelioid hemangioendothelioma and angiosarcoma and synovialosarcoma. We detail here the new WHO classification 2004 explaining the different entities, excluding metastatic tumors which are the most frequent tumors of the pleura.


Asunto(s)
Neoplasias Pleurales/patología , Hemangioendotelioma Epitelioide/patología , Humanos , Linfoma/patología , Mesotelioma/patología , Estadificación de Neoplasias , Neoplasias de Tejido Conjuntivo/patología , Organización Mundial de la Salud
7.
Bull Cancer ; 97(6): 629-41, 2010 Jun.
Artículo en Francés | MEDLINE | ID: mdl-20504759

RESUMEN

Sarcomas comprise a heterogeneous group of mesenchymal neoplasms. They can be grouped into 3 general categories, soft tissue sarcoma, visceral and primary bone sarcoma, which have different staging and treatment approaches. Soft tissue sarcomas are typically classified on the basis of genetic alterations and light-microscopic examination of hematoxylin-eosin-stained tissue, in which recognizable morphological characteristics of normal tissues are identified. Sarcomas are further characterized by histologic grade. The 3 most important prognostic variables are grade, size, and location of the primary tumor. This review includes a discussion of both soft tissue sarcomas (unclassified sarcoma, liposarcoma, leiomyosarcoma, synovial sarcoma, dermatofibrosarcoma protuberans, angiosarcoma, Kaposi sarcoma, gastrointestinal stromal tumor, rhabdomyosarcoma, ...) and primary bone sarcomas (osteosarcoma, Ewing sarcoma and chondrosarcoma). The approach to a patient with a sarcoma begins with a biopsy that obtains adequate tissue for diagnosis without interfering with subsequent optimal definitive surgery. Subsequent treatment depends on the specific type of sarcoma. Due to the absence of clear knowledge for incidence rate, we conducted in 2005 and 2006 an exhaustive analysis of all diagnosed cases in the Rhône-Alpes region. Because sarcomas are relatively uncommon yet comprise a wide variety of different entities, second opinion was systematically performed for all included cases.


Asunto(s)
Neoplasias Óseas/epidemiología , Sarcoma/epidemiología , Neoplasias de los Tejidos Blandos/epidemiología , Adulto , Neoplasias Óseas/genética , Neoplasias Óseas/patología , Niño , Femenino , Francia/epidemiología , Humanos , Incidencia , Masculino , Factores de Riesgo , Sarcoma/genética , Sarcoma/patología , Neoplasias de los Tejidos Blandos/genética , Neoplasias de los Tejidos Blandos/patología
8.
J Mal Vasc ; 34(5): 366-71, 2009 Nov.
Artículo en Francés | MEDLINE | ID: mdl-19782485

RESUMEN

BACKGROUND: Subcutis calcinosis, characterized by abnormal calcium deposition in the skin, is a rare side effect of calcium containing heparins. PATIENTS AND METHODS: Two patients with renal failure presented skin lesions after receiving a calcium-containing heparin treatment. The first patient exhibited erythematous nodules on the abdomen and the second a large erythematous induration of the abdomen and nodules on the thighs. Both had normal blood analysis. The diagnosis of subcutis calcinosis was confirmed by the histological exam showing calcium deposit in the dermis and hypodermis. Outcome was unfavourable in one of the patients who developed a superinfection and skin necrosis lesion requiring surgery at 2 months. DISCUSSION: Subcutis calcinosis is a rare and probably underdiagnosed disease. To our knowledge, only 10 cases have been reported. The pathogenesis is not well-known, tissue damage and calcium disorders are considered as risk factors. The differential diagnoses that can be suspected include calciphylaxis, such as calcifying panniculitis and other local side effects of heparins. Outcome is usually favourable without treatment. CONCLUSION: We describe two cases of iatrogenic subcutis calcinosis after injections of calcium-containing heparins, including the second case of poor outcome. Clinicians should be aware of this adverse effect since other heparins such as fondaparinux or low-weight molecular heparins are contraindicated in patients with renal failure, leading to a large prescription of calcium-containing heparins in this population.


Asunto(s)
Anticoagulantes/efectos adversos , Calcinosis/inducido químicamente , Calcio/efectos adversos , Heparina/efectos adversos , Enfermedades de la Piel/inducido químicamente , Abdomen , Anciano , Anticoagulantes/administración & dosificación , Anticoagulantes/uso terapéutico , Calcinosis/diagnóstico , Calcinosis/cirugía , Calcifilaxia/diagnóstico , Calcio/administración & dosificación , Diabetes Mellitus Tipo 2/complicaciones , Diagnóstico Diferencial , Femenino , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/tratamiento farmacológico , Heparina/administración & dosificación , Heparina/uso terapéutico , Humanos , Inyecciones Subcutáneas , Fallo Renal Crónico/complicaciones , Paniculitis/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/cirugía , Enfermedades Cutáneas Bacterianas/etiología , Tejido Subcutáneo , Muslo , Tromboflebitis/tratamiento farmacológico
9.
Rev Mal Respir ; 26(9): 998-1002, 2009 Nov.
Artículo en Francés | MEDLINE | ID: mdl-19953048

RESUMEN

BACKGROUND: Mucormycosis is a rare fungal infection occurring most frequently in immunocompromised patients. The pathogens are filamentous fungi, order of Mucorales. Disseminated mucormycosis is a severe, life treating disease. Early diagnosis is a major determinant for prognosis, however, it remains difficult. The management consists in an early antifungal therapy using lipid formulation of amphotericin B associated with an extensive surgical debridement. Despite this therapeutic of choice, the mortality of disseminated mucormycosis remains high. OBSERVATION: We report the case of disseminated mucormycosis in a 25 years old woman 9 months after a pulmonary transplantation. The clinical presentation included pulmonary and thyroid localization and the pathogen was Absidia corymbifera. The patient survived thanks to a large surgical debridement, and an early antifungal bitherapy by lipid formulation of amphotericin B and posaconazole. CONCLUSION: The re-emergence and the high mortality of mucormycosis in solid organ transplant receiver show the necessity to find new therapeutic approaches. Posaconazole associated with liposomal amphotericin B could be an interesting option to treat disseminated mucormycosis and improve their outcome.


Asunto(s)
Absidia , Enfermedades Pulmonares Fúngicas/diagnóstico , Trasplante de Pulmón , Mucormicosis/diagnóstico , Infecciones Oportunistas/diagnóstico , Enfermedades de la Tiroides/diagnóstico , Adulto , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Terapia Combinada , Desbridamiento , Femenino , Humanos , Enfermedades Pulmonares Fúngicas/cirugía , Mucormicosis/tratamiento farmacológico , Mucormicosis/cirugía , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/cirugía , Enfermedades de la Tiroides/cirugía , Triazoles/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA